These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25850523)

  • 1. Concurrent Cardioversion of Atrial Fibrillation during ICD Shock Testing.
    Vischer AS; Mutschelknauss M; Kühne MS; Osswald S; Sticherling C; Schaer BA
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):864-9. PubMed ID: 25850523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator.
    Lelakowski J; Tomala I; Cmiel A; Rydlewska A; Majewski J; Małecka B
    Kardiol Pol; 2011; 69(1):17-22. PubMed ID: 21267958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication.
    Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP
    Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing the effectiveness of internal (through implantable cardioverter defibrillator) versus external cardioversion of atrial fibrillation.
    Elayi CS; Parrott K; Etaee F; Shah J; Leung S; Guglin M; Elayi E; Jessinger M; Ogunbayo G; Catanzaro J; Morales G; Darrat Y
    J Interv Card Electrophysiol; 2020 Sep; 58(3):261-267. PubMed ID: 31927665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
    Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
    Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks.
    Miyazaki S; Taniguchi H; Kusa S; Komatsu Y; Ichihara N; Takagi T; Iwasawa J; Kuroi A; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Europace; 2015 Feb; 17(2):289-94. PubMed ID: 25061229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Return of sinus rhythm in permanent atrial fibrillation patients at the time of the testing defibrillation during cardioverter-defibrillator implantation].
    Lelakowski J; Rydlewska A; Tomala I; Majewski J; Małecka B; Kuniewicz M
    Pol Merkur Lekarski; 2010 Aug; 29(170):84-7. PubMed ID: 20842818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Efficacy and Safety of Internal Cardioversion with Implantable Cardioverter Defibrillator Device for Atrial Fibrillation in Systolic Heart Failure Patients.
    Sunman H; Aytemir K; Yorgun H; Canpolat U; Yalçin MU; Maharjan N; Asil S; Şahiner L; Kaya B; Özer N; Oto A
    Ann Noninvasive Electrocardiol; 2016 Mar; 21(2):181-8. PubMed ID: 26084862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of thromboembolic complications in patients with permanent atrial fibrillation undergoing cardioverter-defibrillator implantation.
    Przybylski A; Sterliński M; Lewandowski M; Srzednicki M; Wolski P; Maciag A; Pytkowski M; Kowalik I; Szwed H
    Kardiol Pol; 2002 Oct; 57(10):306-12. PubMed ID: 12917725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation.
    Zareba W; Steinberg JS; McNitt S; Daubert JP; Piotrowicz K; Moss AJ;
    Heart Rhythm; 2006 Jun; 3(6):631-7. PubMed ID: 16731460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
    Hreybe H; Ezzeddine R; Barrington W; Bazaz R; Jain S; Ngwu O; Saba S
    Am J Cardiol; 2006 Feb; 97(4):544-6. PubMed ID: 16461053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinus rhythm restoration affects collagen turnover in patients with persistent atrial fibrillation.
    Kallergis EM; Goudis CA; Kanoupakis EM; Mavrakis HE; Maliaraki NE; Tzanakis N; Vardas PE
    Europace; 2014 Dec; 16(12):1726-30. PubMed ID: 25142742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of atrial arrhythmias in a primary prevention ICD population.
    van Gelder IC; Phan HM; Wilkoff BL; Brown ML; Rogers T; Peterson BJ; Birgersdotter-Green UM
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1070-9. PubMed ID: 21605131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.